Company overview
Basic information
Company name
Vikings LT, MB
Company code
306391808
VAT code
LT100016511714
Registered address
Kazlų Rūda, M. K. Čiurlionio g. 22, LT-69422
Registration date
2023-08-30
Company age: 3 y. 2 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Presented as an image – cannot be copied
Email
Not disclosed
(personal)
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
New construction
Ownership form
Private without foreign capital
MB "Vikings LT"
Company code: 306391808
Address: Kazlų Rūda, M. K. Čiurlionio g. 22, LT-69422
VAT code: LT100016511714
Description
This description was generated by artificial intelligence.
Vikings LT, MB (company code 306391808) is an operational private small partnership registered on 30 August 2023. The company is classified as a micro-sized national private non-financial company with private ownership, meaning more than 50% of its authorised capital is held by Lithuanian natural and legal persons and there is no foreign investor capital. Its governance is CEO only. The company operates in Kazlu Ruda, at M. K. Ciurlionio g. 22, in Kazlu Rudos municipality, Marijampole County. Its EVRK activity is F.41.00.10, New construction. Financially, 2025 was the strongest year in the provided data: revenue reached €312.6K, net profit was €98.7K, and the profit margin was 31.6%. Revenue increased by 97.8% year on year and by 1272.2% over two years. At the end of 2025, equity stood at €105.9K and total assets at €145.3K, with liabilities of €39.4K and an equity ratio of 72.9%. The workforce increased from 3 employees in 2023 and 2024 to 5 employees in 2025 and so far in 2026. The average monthly wage was €899.79 so far in 2026, after €799.18 in 2025 and €1,096.44 in 2024.
Download a detailed company report
Make confident decisions with all the information about Vikings LT, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.